What OsteoBiol does

OsteoBiol is a brand of xenogenic bone substitutes and collagen membranes produced by Tecnoss Dental Srl, a privately held Italian Srl founded by Giuseppe Oliva, MD. The company is headquartered in Pianezza (Turin), Italy, operates with a 1-10 employee footprint, and sells exclusively through a worldwide distributor network with no direct sales force. Its end customers are dental surgeons and implantologists performing bone regeneration and implant procedures.

The product portfolio spans the Gen-Os, Apatos, mp3, Putty, GTO, Sp-Block, Gel 40 and Lamina bone substitutes plus the Evolution and Derma collagen membranes. The underlying technical platform is the proprietary Dual-Phase biomaterial process, which preserves the collagen matrix alongside the mineral phase of bone — a differentiator the company has supported with 25+ years of continuous use and 300+ peer-reviewed publications. The company extends its offering into clinical training courses, delivered in partnership with institutes such as Lake Como Institute and the Academy of Craniofacial Anatomy, and maintains scientific-marketing presence at major congresses (EAO, EAED, Europerio, BBB Academy).

OsteoBiol's revenue model combines hardware sales (consumable bone graft and membrane units sold through distributors) with fees from structured educational courses. Its go-to-market is event-driven and clinically oriented: it relies on peer-reviewed evidence, conference visibility, and training partnerships rather than direct sales infrastructure. The company is founder-controlled, has not raised institutional funding, and provides no public financial disclosure.

Name

OsteoBiol

Legal name

Tecnoss Dental Srl

Website

https://osteobiol.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

1–10 employees

Short description

OsteoBiol, a brand of Tecnoss Dental Srl (Italy), manufactures xenogenic bone substitutes and collagen membranes using proprietary Dual-Phase technology and sells them worldwide through distributors to dental surgeons and implantologists, supplemented by clinical training courses.

Ownership category

akta.pro rank

Product category

Dental Biomaterials

NAICS

Dental Equipment and Supplies Manufacturing (339114), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Dental Equipment & Supplies (3843), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

akta.pro secondary industries

Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE), Periodontal Regeneration (GTR/EMD/Biologics) (HLABACAI), Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)

Keywords

• Bone graft substitutes
• Dental biomaterials
• Collagen membranes
• Implant dentistry
• Xenograft materials

Headquarters

HQ city

Pianezza

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Marketing or Sales, Personnel, Infrastructure

Revenue model

1. Biomaterial Products: Sale of bone substitute biomaterials and collagen membranes for dental surgery bone and soft tissue regeneration. Products include Gen-Os, Apatos, mp3, Putty, GTO, Sp-Block, Gel 40 (bone substitutes) and Evolution, Derma, Lamina (membranes).
2. Educational Courses: International professional education courses for dental surgeons on implant dentistry and bone regeneration techniques. Courses include hands-on training on human cadavers and sinus augmentation procedures.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

OsteoBiol develops, manufactures, and distributes a family of Dual-Phase xenogenic biomaterials — bone substitutes (granules, blocks, gels, putties) and collagen membranes — used by dental surgeons for bone and soft tissue regeneration in implant dentistry. Products are sold worldwide through a network of official distributors and supported by international hands-on training courses, scientific publications, and conference sponsorships.

Product overview

OsteoBiol is a family of biomaterials produced by Tecnoss for bone and soft tissue regeneration in dental surgery, launched in year 2000. The product portfolio includes two main categories: bone substitutes (Lamina, Sp-Block, Gen-Os, Apatos, mp3, GTO, Putty, Gel 40) and collagen membranes (Evolution, Derma). The Dual-Phase biomaterials are of animal origin (porcine and equine) and are chemically similar to autogenous bone. These products serve clinical applications in implant dentistry including alveolar ridge preservation, sinus augmentation, periodontal regeneration, and vertical/horizontal bone augmentation.

Differentiator

Problem solved

Functional benefit

Brands

• OsteoBiol: Family of biomaterials for bone and soft tissue regeneration in dental surgery, produced by Tecnoss®.

Products and services

• Lamina® Collagenic bone barriers made of cortical bone of heterologous origin. After superficial decalcification, Lamina Soft acquires elastic consistency while maintaining compactness. Used as an alternative to autogenous bone cortical plates for various surgical procedures including horizontal augmentation and vestibular socket therapy.
• Sp-Block® Xenogenic cancellous block used for vertical augmentation with the inlay technique in the mandible. The bone matrix is not ceramised and collagen is preserved in its natural structure, accelerating physiological resorption and new bone formation.
• Gen-Os® Dual-Phase heterologous bone substitute with structure similar to human bone. Gradually resorbable with osteoconductive properties, hydrophilic, and can be used alone or with autogenous bone chips in various surgical procedures.
• Apatos® Biocompatible and osteoconductive collagenated xenograft with characteristics similar to human mineralized bone. Features natural microporous consistency that facilitates bone neoformation and long resorption time for volume preservation.
• mp3® Pre-hydrated injectable Dual-Phase biomaterial ready to use for maxillary sinus lift procedures. Dual-Phase granules have characteristics similar to autogenous bone and are gradually resorbed while maintaining original form and volume.
• GTO® Cohesive gradually resorbable and osteoconductive xenograft. The high collagen content allows excellent bone neoformation rate while providing adequate graft volume preservation and alveolar preservation.
• Putty Pre-hydrated injectable bone paste containing collagenated bone granules with granulometry over 300 µm. Designed for peri-implant defects with contained walls to stabilize graft and allow gradual resorption.
• Gel 40 Pre-hydrated collagenated bone gel for transcrestal maxillary sinus floor elevation. The collagen gel gently decolates the Schneiderian membrane, simplifying surgery and promoting soft tissue healing in narrow contained bone defects.
• Evolution Collagen membranes originating from xenogenic pericardium and peritoneum. Dense collagen fiber structure provides high consistency and resistance for graft protection and stabilization in most surgical procedures.
• Derma Xenogenic dermal matrix for soft tissue augmentation. Gradually integrates with autogenous soft tissue through natural collagen fibers, providing stabilization and prolonged protection of underlying graft in alveolar regeneration procedures.
• Hands-on on Human Cadaver Course (international education) International 2-day intensive hands-on professional training course on human cadaver for dental surgeons focused on implant dentistry and bone regeneration techniques, offered in Cremona, Italy, at a 2,500 EUR registration fee.
• Sinus Augmentation Course (international education) International 2-day professional training course on sinus augmentation for dental surgeons, offered in Como, Italy, at a 1,000 EUR registration fee.

Quantifiable outcome

• Gradually resorbed and replaced by newly formed bone for long-term implant stability

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core.

• European Academy for Osseointegration (EAO)coreStrategic or Co-development PartnerOsteoBiol sponsors EAO, a major European organization dedicated to osseointegration research and education in dental implantology
• European Academy of Esthetic Dentistry (EAED)coreStrategic or Co-development PartnerOsteoBiol sponsors EAED, focusing on esthetic dentistry and related regenerative procedures
• EuroperiocoreStrategic or Co-development PartnerOsteoBiol sponsors Europerio, a leading European conference on periodontology and implant dentistry
• BBB AcademycoreStrategic or Co-development PartnerOsteoBiol sponsors BBB Academy, providing education and training in bone regeneration techniques
• Lake Como Institute (LCI)coreStrategic or Co-development PartnerOsteoBiol partners with LCI Implant Advanced Training Center for international education courses on implant dentistry and bone regeneration. Prof. Tiziano Testori serves as Founder and Scientific Director.
• Academy of Craniofacial Anatomy (ACA)coreStrategic or Co-development PartnerOsteoBiol partners with ACA for hands-on cadaver courses on human anatomy for dental surgeons. Dr. Gabriele Rosano serves as Scientific Director.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Dentsply Sirona: Largest diversified dental equipment and supplies manufacturer, with regenerative and surgical consumables competing with OsteoBiol in dental surgery settings. Overlaps in biomaterials, membranes, and implant-adjacent products as part of a much broader portfolio.
• Zimmer Biomet: Large orthopedic and dental medical device company with dental regenerative products (RegenerOss, CopiOs, Puros) used in implantology. Comparable biological bone graft and membrane offering distributed through much larger commercial infrastructure.
• Nobel Biocare: Premium dental implant company owned by Envista, with regenerative biologics offered alongside implants. Competes indirectly with OsteoBiol via implant-plus-biomaterial solutions and global clinical training networks.
• BioHorizons: Dental implant and regenerative products company (Henry Schein) offering bone grafting materials and membranes alongside its implant systems. Competes with OsteoBiol by combining implant and biomaterial sales in dental surgical practices.
• Straumann: Global dental implant leader with a growing regenerative portfolio (XenoFlex, cerabone, membrane lines via partnerships and acquisitions). Competes with OsteoBiol by bundling implants with biomaterials and leveraging unmatched clinical relationships and distribution scale.
• Camlog: European dental implant manufacturer (part of Henry Schein) with biomaterial and membrane offerings sold alongside implants. Comparable in geographic focus (DACH/Europe) and customer base (dental surgeons and implantologists).

Direct peers

• LifeNet Health: Non-profit biologics organization producing allograft and xenograft dental regenerative materials. Direct competitor in the bone graft substitute space with overlapping clinical indications and a similarly science-driven commercial model.
• Geistlich Biomaterials: Swiss manufacturer of Bio-Oss (bovine bone graft) and Bio-Gide (collagen membrane), the global category leader in dental regenerative biomaterials. Directly competes with OsteoBiol across the same implant-dentistry indications with a comparable xenograft-plus-membrane portfolio.
• botiss biomaterials: German dental regenerative biomaterials company offering bone substitutes (cerabone, maxresorb) and collagen membranes (collprotect, Jason membrane). Closely comparable niche European peer with a similar scientific-publication and education-led GTM.

Emerging players

• Salvin Dental Specialties: US-based dental surgical supplier offering bone grafts, membranes, and regenerative products to dental specialists. Comparable niche competitor focused on dental surgery consumables, though smaller and more US-centric than OsteoBiol.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OsteoBiol